Intravitreal bevacizumab for choroidal neovascularization secondary to Vogt-Koyanagi-Harada syndrome

Japanese Journal of Ophthalmology

Volumn 53, Issue 1, 2009, Pages 57-60

  Wu, Lihteh ^a,d   Evans, Teodoro ^a   Saravia, Mario ^b   Schlaen, Ariel ^c   Couto, Cristobal ^c  

^a Instituto de Cirugia Ocular   (Costa Rica)

^b UNIVERSIDAD AUSTRAL   (Argentina)

^c HOSPITAL DE CLÍNICAS JOSÉ DE SAN MARTÍN   (Argentina)

^d NONE   (Costa Rica)

Author keywords

Bevacizumab; Choroidal neovascularization; Posterior uveitis; VEGF; Vogt Koyanagi Harada syndrome

Indexed keywords

AZATHIOPRINE; BEVACIZUMAB; CORTICOSTEROID; STEROID;

ADULT; AGED; ALOPECIA; ARTICLE; CASE REPORT; CATARACT; CATARACT EXTRACTION; CHOROID; DEPIGMENTATION; DRUG SUBSTITUTION; FEMALE; HEADACHE; HUMAN; IRIDOCYCLITIS; JOINT STIFFNESS; LASER COAGULATION; LENS IMPLANT; MALE; OPHTHALMOSCOPY; PHACOEMULSIFICATION; PLEOCYTOSIS; PRIORITY JOURNAL; RETINA DETACHMENT; RETINA MACULA CYSTOID EDEMA; STIFF NECK; SUBRETINAL NEOVASCULARIZATION; VISUAL ACUITY; VISUAL DISORDER; VOGT KOYANAGI SYNDROME;

AGED; ANGIOGENESIS INHIBITORS; ANTIBODIES, MONOCLONAL; CHOROIDAL NEOVASCULARIZATION; FEMALE; FLUORESCEIN ANGIOGRAPHY; HUMANS; INJECTIONS; MALE; MIDDLE AGED; TOMOGRAPHY, OPTICAL COHERENCE; UVEOMENINGOENCEPHALITIC SYNDROME; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VISUAL ACUITY; VITREOUS BODY;

EID: 59449106648     PISSN: 00215155     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10384-008-0600-4     Document Type: Article

References (14)

1. R.W. Read A. Rechodouni N. Butani 2001 Complications and prognostic factors in Vogt-Koyanagi-Harada disease Am J Ophthalmol 131 599 606
2. S. Lertsumitkul S.M. Whitcup R.B. Nussenblatt C.C. Chan 1999 Subretinal fibrosis and choroidal neovascularization in Vogt-Koyanagi-Harada syndrome Graefes Arch Clin Exp Ophthalmol 237 1039 1045
3. R.W. Read N.A. Rao E.T. Cunningham 2000 Vogt-Koyanagi-Harada disease Curr Opin Ophthalmol 11 437 442
4. R.S. Moorthy L.P. Chong R.E. Smith N.A. Rao 1993 Subretinal neovascular membranes in Vogt-Koyanagi-Harada syndrome Am J Ophthalmol 116 164 170
5. P. Bhatnagar K.B. Freund R.F. Spaide 2007 Intravitreal bevacizumab for the management of choroidal neovascularization in pseudoxanthoma elasticum Retina 27 897 902
6. A. Adan M. Navarro R.P. Casaroli-Marano 2007 Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome Graefes Arch Clin Exp Ophthalmol 245 1873 1875
7. S. Mandal P. Venkatesh R. Sampangi S. Garg 2007 Intravitreal bevacizumab (Avastin) as primary treatment for myopic choroidal neovascularization Eur J Ophthalmol 17 620 626
8. H. Inomata M. Minei Y. Taniguchi F. Nishimura 1983 Choroidal neovascularization in long-standing case of Vogt-Koyanagi-Harada disease Jpn J Ophthalmol 27 9 26
9. R.E. Foster C.D. Knight C.Y. Lowder 2000 Subfoveal choroidal neovas cular membrane excision in Vogt-Koyanagi-Harada syndrome Retina 20 547 549
10. M.E. Farah R.A. Costa C. Muccioli 2002 Photodynamic therapy with verteporfin for subfoveal choroidal neovascularization in Vogt-Koyanagi-Harada syndrome Am J Ophthalmol 134 137 139
11. S.R. Nowilaty M. Bouhaimed 2006 Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease Br J Ophthalmol 90 982 986
12. A. Ketata Z. Z. Ben D. Hajji 2006 Two cases of subretinal neovascular membrane in Vogt-Koyanagi-Harada syndrome [in French] J Fr Ophtalmol 29 302 306
13. R. Pedersen W. Soliman H. Lund-Andersen M. Larsen 2007 Treatment of choroidal neovascularization using intravitreal bevacizumab Acta Ophthalmol Scand 85 526 533
14. A.P. Adamis D.T. Shima 2005 The role of vascular endothelial growth factor in ocular health and disease Retina 25 111 118